Application Sponsors
ANDA 212082 | LANNETT CO INC | |
Marketing Status
Application Products
001 | CAPSULE;ORAL | 300MG;50MG;40MG | 0 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-12-17 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
LANNETT CO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 212082
[companyName] => LANNETT CO INC
[docInserts] => ["",""]
[products] => [{"drugName":"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","activeIngredients":"ACETAMINOPHEN; BUTALBITAL; CAFFEINE","strength":"300MG;50MG;40MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/17\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-12-17
)
)